SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-011323
Filing Date
2019-02-28
Accepted
2019-02-28 07:17:03
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-5576_18k.htm 8-K 23889
2 EX-99.1 a19-5576_1ex99d1.htm EX-99.1 415101
3 GRAPHIC g55761mm01i001.jpg GRAPHIC 5514
  Complete submission text file 0001104659-19-011323.txt   447957
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 19640409
SIC: 2834 Pharmaceutical Preparations